- Home
- SND vs SRZN Comparison
SND vs SRZN Comparison
Compare SND & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SND | SRZN |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | 318 | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.5M | 210.3M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SND | SRZN |
|---|---|---|
| Price | $5.21 | $28.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | ★ 398.1K | 72.0K |
| Earning Date | 05-12-2026 | 03-23-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $330,153,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $166.67 | ★ N/A |
| Revenue Growth | ★ 6.03 | N/A |
| 52 Week Low | $1.76 | $7.11 |
| 52 Week High | $5.59 | $29.60 |
Technical Indicators
Market Signals| Indicator | SND | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 68.80 | 59.78 |
| Support Level | $1.92 | $23.53 |
| Resistance Level | $5.59 | $28.78 |
| Average True Range (ATR) | 0.21 | 2.13 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 89.20 | 74.83 |
Price Performance
Historical ComparisonAbout SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).